Stryker Valuation

SYK Stock  USD 358.71  9.13  2.61%   
At this time, the company appears to be undervalued. Stryker has a current Real Value of $404.17 per share. The regular price of the company is $358.71. Our model measures the value of Stryker from inspecting the company fundamentals such as Operating Margin of 0.24 %, shares outstanding of 380.26 M, and Return On Equity of 0.18 as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend picking up undervalued stocks and discarding overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Price Book
7.166
Enterprise Value
143.2 B
Enterprise Value Ebitda
29.0188
Price Sales
6.6005
Forward PE
29.5858
Undervalued
Today
358.71
Please note that Stryker's price fluctuation is very steady at this time. Calculation of the real value of Stryker is based on 3 months time horizon. Increasing Stryker's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Stryker is useful when determining the fair value of the Stryker stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Stryker. Since Stryker is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Stryker Stock. However, Stryker's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  358.71 Real  404.17 Target  317.09 Hype  358.71 Naive  355.03
The real value of Stryker Stock, also known as its intrinsic value, is the underlying worth of Stryker Company, which is reflected in its stock price. It is based on Stryker's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Stryker's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Stryker's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
322.84
Downside
404.17
Real Value
405.30
Upside
Estimating the potential upside or downside of Stryker helps investors to forecast how Stryker stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Stryker more accurately as focusing exclusively on Stryker's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
2.282.362.48
Details
Hype
Prediction
LowEstimatedHigh
357.58358.71359.84
Details
Potential
Annual Dividend
LowForecastedHigh
1.951.961.97
Details
30 Analysts
Consensus
LowTarget PriceHigh
288.55317.09351.97
Details

Stryker Investments

(923.4 Million)

Stryker Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Stryker's current stock value. Our valuation model uses many indicators to compare Stryker value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Stryker competition to find correlations between indicators driving Stryker's intrinsic value. More Info.
Stryker is rated third in price to book category among related companies. It is rated fourth in beta category among related companies totaling about  0.13  of Beta per Price To Book. The ratio of Price To Book to Beta for Stryker is roughly  7.97 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Stryker by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Stryker's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Stryker's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Stryker's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Stryker and how it compares across the competition.

About Stryker Valuation

The stock valuation mechanism determines the current worth of Stryker on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Stryker. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Stryker based exclusively on its fundamental and basic technical indicators. By analyzing Stryker's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Stryker's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Stryker. We calculate exposure to Stryker's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Stryker's related companies.
Last ReportedProjected for 2024
Gross Profit13.1 B13.7 B
Pretax Profit Margin 0.18  0.13 
Operating Profit Margin 0.19  0.14 
Net Profit Margin 0.15  0.1 
Gross Profit Margin 0.64  0.50 

Stryker Quarterly Retained Earnings

16.77 Billion

8 Steps to conduct Stryker's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Stryker's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Stryker's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Stryker's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Stryker's revenue streams: Identify Stryker's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Stryker's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Stryker's growth potential: Evaluate Stryker's management, business model, and growth potential.
  • Determine Stryker's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Stryker's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.
Stryker's stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether Stryker's value is low or high relative to the company's performance and growth projections. Determining the market value of Stryker can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of Stryker represents a small ownership stake in the entity. As a stockholder of Stryker, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.

Stryker Dividends Analysis For Valuation

Dividend Paid And Capex Coverage Ratio is expected to rise to 6.91 this year, although the value of Dividends Paid is projected to rise to (1.1 B). . At this time, Stryker's Retained Earnings are quite stable compared to the past year. Price Earnings Ratio is expected to rise to 48.53 this year, although the value of Retained Earnings Total Equity will most likely fall to about 10.2 B.
Last ReportedProjected for 2024
Dividends Paid-1.1 B-1.1 B
Dividend Yield 0.01  0.01 
Dividend Payout Ratio 0.36  0.19 
Dividend Paid And Capex Coverage Ratio 6.58  6.91 
There are various types of dividends Stryker can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Stryker shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Stryker directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Stryker pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Stryker by the value of the dividends paid out.

Stryker Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Stryker does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding383.7 M
Quarterly Earnings Growth Y O Y1.027
Forward Price Earnings29.5858

Stryker Current Valuation Indicators

Valuation refers to the process of determining the present value of Stryker and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Stryker we look at many different elements of the entity such as Stryker's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Stryker's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Stryker's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Stryker, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Stryker's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Stryker's worth.
When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.
For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Stryker Stock analysis

When running Stryker's price analysis, check to measure Stryker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stryker is operating at the current time. Most of Stryker's value examination focuses on studying past and present price action to predict the probability of Stryker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stryker's price. Additionally, you may evaluate how the addition of Stryker to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stocks Directory
Find actively traded stocks across global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Valuation
Check real value of public entities based on technical and fundamental data
Is Stryker's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.027
Dividend Share
3.05
Earnings Share
8.23
Revenue Per Share
53.999
Quarterly Revenue Growth
0.118
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.